ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,724.30
-0.33%
S&P ASX All Technology
3,092.70
-1.13%
Brent Oil
82.275
0.00%
US Dollar vs AUD
1.51378
0.00%
Bitcoin
66,248.28
0.09%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. SciSparc Ltd (SPRC)

  7. SciSparc Ltd (SPRC) News

SPRC SciSparc Ltd

0.90
-0.0323 (-3.46%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
SciSparc Ltd SPRC NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0323 -3.46% 0.90 14:00:12
Open Price Low Price High Price Close Price Previous Close
0.93 0.905101 0.94 0.93 0.9323
more quote information »

Recent News

Date Time Source Heading
15/6/202406:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
03/6/202421:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/5/202421:17GLOBESciSparc Secures Strategic Advantage with Grant of European..
11/4/202422:15GLOBESciSparc to Acquire AutoMax
21/3/202423:58GLOBESciSparc: MitoCareX Unveils Groundbreaking Discovery of..
18/3/202422:29GLOBESciSparc Granted Another Patent, Strengthening its Core..
14/3/202423:49GLOBESciSparc Achieves Major Milestone with First Patient Dosed..
12/3/202423:14GLOBESciSparc: MitoCareX Reveals Promising Results with Discovery..
09/3/202401:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/3/202423:11GLOBESciSparc Announces Enrollment of First Patient for its..
07/3/202423:49GLOBESciSparc Granted Patent for Core Technology in Multiple..
07/3/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
07/3/202408:41GLOBESciSparc Issued Canadian Patent for Opioids Reduction Use in..
01/3/202401:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
01/3/202400:35GLOBESciSparc Delivers Treatment for Autism Spectrum Disorder..
28/2/202408:15EDGAR2Form F-1 - Registration statement for certain foreign..
28/2/202400:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/2/202423:58GLOBEClearmind Medicine Submits Three Additional International..
21/2/202408:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/2/202423:14GLOBESciSparc and Clearmind Continue to Strengthen International..
13/2/202408:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/1/202408:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/1/202423:18GLOBESciSparc Announces Initiation of Patient Recruitment for its..
26/1/202401:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/1/202423:42GLOBESciSparc Ltd. Announces $20 Million Standby Equity Purchase..
22/1/202422:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/1/202401:28GLOBESciSparc Advances the Acquisition Process of a Leading..
04/1/202423:18GLOBESciSparc and Clearmind Medicine Reflect on Successful..
14/12/202300:18GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
09/12/202300:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/12/202301:05GLOBESciSparc Provides Updates Regarding the Non-Binding Letter..
02/12/202300:14GLOBEWeight Loss Treatment: SciSparc’s Obesity Drug Showed..
29/11/202308:55EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
29/11/202308:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/11/202300:55GLOBESciSparc Adopts Limited Duration Shareholder Rights Plan
29/11/202300:25GLOBESciSparc Announces Positive Results from its Weight Loss and..
28/11/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/11/202300:41GLOBESciSparc Announces Positive Results for MitoCareX Bio with..
25/11/202300:55GLOBENew Hope for Children: SciSparc's patented CBD- Enhanced..
23/11/202308:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/11/202323:42GLOBESciSparc Signs Non-Binding Letter of Intent to Merge with..
21/11/202308:22EDGAR2Form F-3/A - Registration statement by foreign private..
16/11/202300:01GLOBESciSparc Celebrates Major Breakthrough: Positive Results..
11/11/202301:10GLOBESciSparc Aims to Change Tourette Syndrome Treatments; Will..
04/11/202307:06EDGAR2Form F-3 - Registration statement by foreign private issuers
31/10/202323:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
31/10/202322:38GLOBESciSparc Granted Patent from the Australian Patent Office..
24/10/202322:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
24/10/202322:20GLOBESciSparc Granted Patent for its Core Technology From the..

Your Recent History

NASDAQ
SPRC
SciSparc
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved